Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Idexx Laboratories

IDXX Clue Score66

United States Fiscal year ends December CIK 0000874716 Results filed 2 Nov 2026

Add to watchlist

What the insiders did Net selling

Individual transactions

Insider

Date

Role

Action

Price

Amount

Daniel M Junius

4 Nov 2026

Director

Sell

500

$701.69

$350.84K

Daniel M Junius

4 Nov 2026

Director

Sell

700

$705.78

$494.05K

Michael Lane

4 Nov 2026

Executive Vice President

Sell

1,677

$687.46

$1.15M

Michael Lane

4 Nov 2026

Executive Vice President

Sell

2,059

$689.70

$1.42M

Michael Lane

4 Nov 2026

Executive Vice President

Sell

243

$687.85

$167.11K

Nimrata Hunt

3 Mar 2026

Executive Vice President

Sell

1,758

$634.57

$1.12M

Nimrata Hunt

26 Feb 2026

Executive Vice President

Sell

2,693

$661.54

$1.78M

Show all 66 transactions →

What was left out

Form 4 filings counted 45

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 50

Sales at will 7

Transactions with no price 0

Shares from compensation/vesting 115,424

History held since 1 Nov 2006